Delivery Order SPE2DB20D2104-SPE2DB25FNARG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,528.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This competitively awarded, non-set-aside contract involves firm fixed pricing and is scheduled for completion by September 2, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded a delivery order valued at $2,455.38 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, with an ultimate completion date of July 30, 2025. The contract utilized firm fixed pricing with no set-aside designation, indicating open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a $6,333.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units), with completion expected by August 28, 2025. This non-set-aside competitive award represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,909.49 to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,913.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 14, 2025, with completion scheduled for August 15, 2025. This non-set-aside competitive award represents a pharmaceutical delivery under the agency's medical supply procurement operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal healthcare systems and...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $7,745.89 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on August 26, 2025. The contract calls for the delivery of 180-count bottles of Janumet XR 50-1,000 mg tablets with a ceiling value of $4,186.29 under a firm fixed price arrangement. The award is non-set-aside and represents a competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNARGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order represents a single transaction under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems and other federal customers. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/16/25 |